Subscribe to our newsletter
Get the latest content first.
Patient Interviews & Videos
Spotlight On….
Welcome to the Thyroid Project
Metabolism.com presents the introductory patient interview for The Thyroid Project during which she describes the predicament of someone who has been unsuccessfully treated for hypothyroidism.
The Prediabetes Puzzle: What the Blood Tests Mean
Diabetes can be defined simply as elevated blood sugar levels. What exactly is high blood sugar and when should someone be concerned about their level? Does having prediabetes mean diabetes is around the corner? Metabolism.com tackles this tricky but important topic in this comprehensive review.
Unmasking the Dark Side of the Ozempic Craze
The craze for Ozempic and related medications for weight loss has come at a great price both economically and possibly health-wise for users of these medications. Major pharmaceutical companies are making billions of dollars of profit while small start up companies offering bootlegged versions of these drugs along with generic drug makers are hoping to join in the bonanza, as well.
Anti-obesity Medications 2023: The Controversy Continues
Shortages caused by explosive use of a new class of anti-obesity medications has caused hardship for those who need them as well as those who can’t afford them. This review covers 60 years of controversy in the anti-obesity field.
Eight Tips to Get Your Body Moving
Finding the time, energy and motivation for exercise can be challenging. On the other hand, the benefits of regular exercise can result in a thinner, happier, you. Here are 8 practical tips just about anyone can follow to get an exercise routine off to a pain free, inexpensive and successful start.
Weight Loss Drugs: An Overview for 2022
By Gary M. Pepper, M.D. , Sam Jeans MSc To help...
Three Reliable Strategies for Reducing Abdominal (Belly) Fat
The good news is that it’s possible for virtually anyone to reduce abdominal fat. The bad news is, there’s no real shortcuts and you can’t cheat your way to a trim waist!
Popular On Metabolism.com
Welcome to the Thyroid Project
Metabolism.com presents the introductory patient interview for The Thyroid Project during which she describes the predicament of someone who has been unsuccessfully treated for hypothyroidism.
The Prediabetes Puzzle: What the Blood Tests Mean
Diabetes can be defined simply as elevated blood sugar levels. What exactly is high blood sugar and when should someone be concerned about their level? Does having prediabetes mean diabetes is around the corner? Metabolism.com tackles this tricky but important topic in this comprehensive review.
Unmasking the Dark Side of the Ozempic Craze
The craze for Ozempic and related medications for weight loss has come at a great price both economically and possibly health-wise for users of these medications. Major pharmaceutical companies are making billions of dollars of profit while small start up companies offering bootlegged versions of these drugs along with generic drug makers are hoping to join in the bonanza, as well.
Anti-obesity Medications 2023: The Controversy Continues
Shortages caused by explosive use of a new class of anti-obesity medications has caused hardship for those who need them as well as those who can’t afford them. This review covers 60 years of controversy in the anti-obesity field.
Eight Tips to Get Your Body Moving
Finding the time, energy and motivation for exercise can be challenging. On the other hand, the benefits of regular exercise can result in a thinner, happier, you. Here are 8 practical tips just about anyone can follow to get an exercise routine off to a pain free, inexpensive and successful start.
Weight Loss Drugs: An Overview for 2022
By Gary M. Pepper, M.D. , Sam Jeans MSc To help...
Three Reliable Strategies for Reducing Abdominal (Belly) Fat
The good news is that it’s possible for virtually anyone to reduce abdominal fat. The bad news is, there’s no real shortcuts and you can’t cheat your way to a trim waist!
Welcome to the Thyroid Project
Metabolism.com presents the introductory patient interview for The Thyroid Project during which she describes the predicament of someone who has been unsuccessfully treated for hypothyroidism.
Unmasking the Dark Side of the Ozempic Craze
The craze for Ozempic and related medications for weight loss has come at a great price both economically and possibly health-wise for users of these medications. Major pharmaceutical companies are making billions of dollars of profit while small start up companies offering bootlegged versions of these drugs along with generic drug makers are hoping to join in the bonanza, as well.
Anti-obesity Medications 2023: The Controversy Continues
Shortages caused by explosive use of a new class of anti-obesity medications has caused hardship for those who need them as well as those who can’t afford them. This review covers 60 years of controversy in the anti-obesity field.
Subscribe to our newsletter
Get the latest content first.
Our Topics
Similar Articles
Welcome to the Thyroid Project
The mission of the The Thyroid Project is to encourage sharing of information and experience between the public and the medical community about the treatment of hypothyroidism (low thyroid function). For at least the past few decades there is a growing awareness of “something missing†in the way suffers of hypothyroidism are treated for their disease.
Too many patients, as documented in an on-line study of 12,000 individuals conducted by the American Thyroid Association published in June 2018, (https://doi.org/10.1089/thy.2017.0681) , complain of persistent symptoms of hypothyroidism despite what their doctors believe is successful treatment with levothyroxine (brands include Synthroid, Unithroid, Tirosent, Levoxl). We believe something needs to be done to resolve this conflict between patients and their doctors.
The Prediabetes Puzzle: What the Blood Tests Mean
Diabetes can be defined simply as elevated blood sugar levels. What exactly is high blood sugar and when should someone be concerned about their level? Does having prediabetes mean diabetes is around the corner? Metabolism.com tackles this tricky but important topic in this comprehensive review.
Unmasking the Dark Side of the Ozempic Craze
By Gary M. Pepper, M.D. Ozempic, Rybelsus, Trulicity, Wegovy, Saxenda are the central players in the weight loss craze sweeping across the globe. Metabolisim.com has been monitoring this phenomenon from its beginnings in 2008 with its report “Lizard Spit Reduces Blood Sugar and Appetite”, regarding the first drug in this class, Byetta (exenatide). Caught In the middle of the current chaos are the medical experts who treat diabetes and have been prescribing these medications for more than a decade. Here is a brief commentary from one such board certified endocrinologist; “I started treating Type 2 diabetics with GLP-1 agonists more than 10 years ago. In some respects, these medications have revolutionized the treatment of diabetes by lowering blood sugar effectively and promoting weight loss at the same time, a unique combination of benefits. Not everyone benefits from these drugs to the same degree unfortunately, and I have seen lots of patients experience unacceptable side effects from them. Nothing though, has prepared me for what is happening now. Too often, I find myself confronting someone who expects me to prescribe one of these drugs just so they can lose weight. Sadly, one extreme example was someone who, despite battling a life threatening medical condition, was insistent on getting a prescription. At the same time my diabetic patients are scrambling to find a place to buy their medications if they can even afford it. It is disheartening, to say the least, and I dread the negative interactions with some of my patients I now face almost daily.”
Off- Label Use
The FDA is the U.S. government’s department tasked with evaluating and approving drugs for specific medical conditions. When a new medication is approved for treating a medical condition by the FDA the agency will, at the same time, set strict guidelines for exactly which patients may use the newly approved drug. When a medication is used “off-label” it means that these limitations are being overridden by the provider for a potential benefit which outweighs the drugs risks. It is a general misconception that off-label means illegal; it does not. This practice has been going on for ages and more than 20% of prescriptions in the United States are prescribed off-label. A common example is the use of beta-blockers (approved for heart problems) for the treatment of performance anxiety.
GLP-1 agonist drugs, as discussed recently by metabolism.com. were originally approved for the treatment of Type 2 diabetes in adults. In the past few years most of these same medications have gained unprecedented popularity for their “off-label” weight loss benefit. Of the 5 GLP-1 agents presently in U.S. pharmacies only Wegovy (semaglutide) and Saxenda (liraglutide) are FDA approved for treating obesity. Of these two, Wegovy is the newer and had been much more popular that its sister drug Saxenda, probably due to being dosed only once weekly compared to daily for Saxenda and less likely to cause side effects. Due to Wegovy’s soaring popularity, its manufacturer, Novo Nordisk, increased the price of Wegovy two times since its initial release.
Anti-obesity Medications 2023: The Controversy Continues
by Gary M. Pepper, M.D. and Sam Jeans, MSc The global anti-obesity drug market, in 2021was valued at over $2 billion. Within one year this figure had skyrocketed to $8 billion and is expected to climb to nearly $ 20 billion by 2027. This astounding growth is a reflection of soaring obesity rates, and the arrival of a new class of weight loss medication fueling a craze both in the USA and across the world.
The FDA and global health regulators, until very recently, had maintained a very tight ship when it comes to treating obesity with medication, placing the emphasis on diet and exercise rather than weight loss drugs. Since the 80s, anti-obesity drugs continued to be controversial, and a more stringent FDA implemented ongoing safety trials along with other precautions. There is some speculation that a shift in attitude toward approval of weight loss medication by the FDA , is underway
Weight loss drug controversies are far from over and, in fact, may soon rival the amphetamine crisis of the 70’s. For that reason, metabolism.com has felt it important to provide our guide to weight loss drug issues, past and present.
Anti-Obesity Drugs Timeline
Prescription drugs for lifestyle diseases such as obesity were marketed heavily throughout the 1950s to the 1970s. Amphetamines entered the public domain after the Second World War where they were used extensively in the military.
In the 50s, walk-in clinics prescribed diet pills with other medications almost at random, with or without genuine concern for one’s weight. These brightly colored pills became known as “rainbow pills”.
In the 1960s and 1970s, the so-called “rainbow pill diet” of pills was finally coming to an end as the FDA began to systematically ban many of the drugs involved. A high-profile expose by investigative journalist Susanna Mcbee, published in Life magazine, brought attention to this new modern public health crisis.
The rainbow pill diet combined amphetamines, laxatives, thyroid hormones, and even diuretics to produce extreme weight loss, combined with benzodiazepines, barbiturates, and steroids to reduce side effects, and antidepressants to suppress medication-induced insomnia and anxiety.
In 1968, rainbow pills were linked to over 60 deaths, with numerous accounts of their devastating impact surfacing in the news and media. Within just two months, 48 million pills were seized and destroyed. Nevertheless, amphetamine-based diet pills remained extremely popular throughout the 1970s. In 1978, some 3.3 million prescriptions for amphetamines were written each year, with some 50 million pills a year ending up in the black market.
In 1979, the FDA banned amphetamines as a weight loss aid, but that is hardly the end of the USA’s love affair with obesity medication.
Here’s a brief timeline of recent anti-obesity drugs: